Fig. 1From: Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomasOverall (a) and progression-free (b), local (c) and extracranial distant progression-free survival (d) in 70 patients with LCNEC.Back to article page